Systemic sclerosis-related fecal incontinence: a scoping review focusing on a neglected manifestation.

François Zimmermann, Alain Lescoat, Dinesh Khanna, Zsuzsanna H McMahan, Charles D Murray, Michael Hughes

Journal: Rheumatology (Oxford, England) 2025;64(4):1609-1626

PMID: 39693125

Abstract

OBJECTIVES

This scoping review sought to summarize the current knowledge on the epidemiology, pathogenesis and clinical presentation of, and the investigations that may help characterize faecal incontinence (FI) in patients with SSc.

METHODS

The planned scoping review was based on the methodological framework proposed by Arksey and O'Malley. Two databases were screened: PubMed (Medline), (Web of Science), and data extraction was performed using a predefined template.

RESULTS

A total of 454 abstracts were screened and 61 articles were finally included, comprising 32 original articles. The prevalence of FI was 0.4% to 77% in original articles that did not use FI among the mandatory inclusion criteria. Internal anal sphincter was reported as more impacted than external sphincter and vasculopathy of arterioles and extracellular matrix deposition with fibrous replacement of the internal sphincter were the key underlaying pathogenic events. The most represented patient-reported outcome in original articles was the Wexner FI score (22% of original articles) followed by the UCLA SCTC-GIT 2.0 (16% of original articles). Although there is no validated diagnostic approach for FI in SSc, 47% of original articles used anorectal manometry to assess rectal physiology in SSc patients. Conservative measures to treat either liquid or hard stool including anti-diarrhoeal medications and dietary adjustments were the first step of proposed FI management in included narrative reviews and guidelines.

CONCLUSION

This is the first scoping review exploring FI in SSc. We propose a new research agenda which may help improve treatment strategies and foster research focusing on a neglected manifestation of SSc.

© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].

Address: Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France.; EHESP, Irset (Institut de Recherche en Santé, Univ Rennes, CHU Rennes, Inserm, Environnement et Travail) - UMR_S 1085, Rennes, France.; Department of Gastroenterology, Royal Free London, London, UK.; Department of Internal Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.; Department of Internal Medicine, Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.; Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Salford, UK.; Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Division of Rheumatology, Department of Internal Medicine, UTHealth Houston, Houston, TX, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.